Comparison Between Subacromial Infiltrations
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03303001 |
Recruitment Status :
Completed
First Posted : October 5, 2017
Last Update Posted : February 2, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Subacromial Bursitis Subacromial Impingement Syndrome Rotator Cuff Impingement Syndrome | Procedure: Subacromial high volume infiltration Procedure: Subacromial conventional infiltration | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 22 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Treatment |
Official Title: | Subacromial Injection of High Volume Versus Conventional Steroid Injection Guided by Ultrasound in Shoulder Pain. Randomized Controlled Trial |
Actual Study Start Date : | October 10, 2017 |
Actual Primary Completion Date : | March 30, 2020 |
Actual Study Completion Date : | April 30, 2020 |
Arm | Intervention/treatment |
---|---|
Experimental: Subacromial high volume infiltration
This group received an subacromial infiltration guided by ultrasound, of 50 mL of solution. This solution mix: 2 mL of methylprednisolone (40 mg) plus 8 mL of lidocaine simple plus 10 mL of ropivacaine 7.5% plus 30 mL of saline solution.
|
Procedure: Subacromial high volume infiltration
This group will receive a high volume dose of a mix of methylprednisolone (40 mg in 2 mL) plus ropivacaine at 7.5% plus simple lidocaine plus saline solution for a total of 50 mL
Other Name: subacromial infiltration |
Active Comparator: Subacromial conventional infiltration
This group received an subacromial infiltration guided by ultrasound of 10 mL of solution. This solution mix: 2 mL of methylprednisolone (40 mg) plus 3 mL of lidocaine simple plus 5 mL of ropivacaine 7.5%
|
Procedure: Subacromial conventional infiltration
This group will receive a mix of solution of 2 mL of 40 mg of methylprednisolone plus 5 ml of ropivacaine at 7.5% plus 3 mL of lidocaine simple for a total of 10 ml
Other Name: subacromial infiltration |
- Visual Analogue Scale [ Time Frame: Three months ]Measure the pain in patient, when 0 is no pain and 10 worst pain
- Shoulder Pain and Disability Index (SPADI) [ Time Frame: Three months ]Evaluates pain and function in 13 questions, with a scale from 0 to 10, normal shoulder is 0 and worst is 130
- Simple Shoulder Test (SST) [ Time Frame: Three months ]Twelve questions based on pain, function and range of motion, when 0 is an affected shoulder and 12 in a normal shoulder

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Shoulder impingement syndrome
- Three months of history of pain and disability of the shoulder
- Failure to conservative initial treatment with NSAID's and rehabilitation
Exclusion Criteria:
- Rotator cuff tears
- Previous shoulder surgeries of any kind
- Glenohumeral or acromioclavicular arthritis
- Metabolic disease like diabetes mellitus or rheumatoid arthritis
- Previous infiltration in the past sixth months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03303001
Mexico | |
Universidad Autonoma de Nuevo Leon | |
Monterrey, Nuevo Leon, Mexico, 64480 | |
Universidad Autonoma de Nuevo Leon | |
Monterrey, Nuevo Leon, Mexico, 66460 |
Principal Investigator: | Carlos Acosta-Olivo, MD, PhD | Universidad Autonoma de Nuevo Leon |
Responsible Party: | Carlos A Acosta-Olivo, Professor, Universidad Autonoma de Nuevo Leon |
ClinicalTrials.gov Identifier: | NCT03303001 |
Other Study ID Numbers: |
OR17-00006 |
First Posted: | October 5, 2017 Key Record Dates |
Last Update Posted: | February 2, 2021 |
Last Verified: | January 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Plan Description: | Actually is an active study |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | Yes |
subacromial infiltration high volumen shoulder pain |
Shoulder Impingement Syndrome Bursitis Syndrome Rotator Cuff Injuries Disease Pathologic Processes |
Joint Diseases Musculoskeletal Diseases Rupture Wounds and Injuries Shoulder Injuries Tendon Injuries |